NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Ownership - Who owns Greenwich Lifesciences?

Insider buying vs selling

Have Greenwich Lifesciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Snehal PatelCEO and CFO2025-04-253,600$9.88
$35.57kBuy
Snehal PatelCEO and CFO2025-04-175,400$8.98
$48.49kBuy
Snehal PatelCEO and CFO2025-04-073,600$9.10
$32.76kBuy
Snehal PatelCEO and CFO2025-04-045,500$8.73
$48.02kBuy
Snehal PatelCEO and CFO2025-01-102,500$12.51
$31.28kBuy
Snehal PatelCEO and CFO2025-01-071,800$13.75
$24.75kBuy
Snehal PatelCEO and CFO2025-01-061,100$13.31
$14.64kBuy
Snehal PatelCEO and CFO2025-01-033,400$12.95
$44.03kBuy
Snehal PatelCEO and CFO2025-01-022,000$11.97
$23.94kBuy
Snehal PatelCEO and CFO2024-12-312,400$11.36
$27.26kBuy

1 of 2

GLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLSI insiders and whales buy or sell their stock.

GLSI Shareholders

What type of owners hold Greenwich Lifesciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Snehal Patel71.91%9,613,078$88.44MInsider
Kinnary Patel9.95%1,329,590$12.23MInsider
Kenneth Hallock5.94%794,308$7.31MInsider
David McWilliams4.64%620,301$5.71MInsider
Blackrock Inc2.63%352,191$3.24MInstitution
Eric Rothe2.34%313,226$2.88MInsider
Vanguard Group Inc2.02%270,306$2.49MInstitution
Jaye Thompson1.98%264,148$2.43MInsider
Geode Capital Management LLC1.02%137,010$1.26MInstitution
Frank Joseph Daugherty0.67%90,121$829.11kInsider

1 of 3

GLSI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLSI8.19%91.81%Net BuyingNet Buying
SEER46.79%52.68%Net SellingNet Selling
ELTX9.95%70.40%Net Buying
BHST0.74%0.00%
TARA47.68%52.32%Net SellingNet Buying

Greenwich Lifesciences Stock Ownership FAQ

Who owns Greenwich Lifesciences?

Greenwich Lifesciences (NASDAQ: GLSI) is owned by 8.69% institutional shareholders, 97.43% Greenwich Lifesciences insiders, and 0.00% retail investors. Snehal Patel is the largest individual Greenwich Lifesciences shareholder, owning 9.61M shares representing 71.91% of the company. Snehal Patel's Greenwich Lifesciences shares are currently valued at $88.44M.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.